Clinical Patterns and Treatment Outcome in Patients with Melancholic, Atypical and Non-Melancholic Depressions

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Gili, Margalida ^a,b   Roca, Miquel ^a,b   Armengol, Silvia ^c   Asensio, David ^c   Garcia Campayo, Javier ^b,d   Parker, Gordon ^e  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b Red de Actividades Preventivas y Promoción de la Salud en Atención Primaria RediAPP   (Spain)

^c Almirall Medical Department ^*  (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; ATYPICAL DEPRESSION; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; MULTICENTER STUDY; REMISSION; SUBSTANCE ABUSE; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84868133930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048200     Document Type: Article

References (50)

1. Baumeister H, Parker G (2011) Meta-review of depressive subtyping models. J Affect Disord, doi:10.1016/j.jad.2011.07.015.
2. Sun N, Li Y, Cai Y, (2012) A Comparison of melancholic and nonmelancholic recurrent major depression in Han chinese women. Depression and Anxiety 29: 4-9.
3. Ambrosini A, Stanghellini G, Langer AI, (2011) Typus melancholicus from Tellenbach up to present day: a review about the premorbid personality vulnerable to melancholia. Actas Esp Psiquiatr 39: 302-11.
4. Fink M, Taylor MA, (2007) Resurrecting melancholia. Acta Psychiatr Scand 115: 14-20.
5. Thase ME, (2009) Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria. Neuropsychopharmacol 34: 2633-2641.
6. Maj M, (2011) Refining the diagnostic criteria for major depression on the basis of empirical evidence. Acta Psychiatr Scand 123: 317.
7. Parker G, Kathryn F, Barret M, Synnot H, Breakspear M, et al. (2010) Inching toward Bethlehem: Mapping melancholia. J Affect Disord 123: 291-298.
8. Fink M, Bolwig TG, Parker G, Shorter E, (2007) Melancholia: restoration in psychiatric classification recommended. Acta Psychiatr Scand 115: 89-92.
9. Kocsis JH, (2010) Melancholia as a Distinct Mood Disorder? Recommendations for DSM-5. Am J Psychiatry 12: 167.
10. Leventhal AM, Rehm lP, (2005) The empirical status of melancholia: implications for psychology. Clin Psychol Rev 25: 25-44.
11. Parker G, (2011) Classifying clinical depression: an operational proposal. Acta Psychiatr Scand 123: 314-316.
12. Shorter E, (2007) The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand 115: 5-13.
13. Khan AY, Carrithers J, Preskorn SH, Lear R, Wisniewski SR, et al. (2006) Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry 18: 91-8.
14. Rush AJ, (2007) The varied clinical presentations of major depressive disorder. J Clin Psychiatry 68: 4-10.
15. Monzón S, Gili M, Vives M, Serrano MJ, Bauzá N, et al. (2010) Melancholic versus non-melancholic depression: differences on cognitive function. A longitudinal study protocol. BMC Psychiatry 17: 10-48.
16. Perry PJ, (1996) Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord 39: 1-6.
17. Brown C, Battista DR, Sereika SM, Bruehlman RD, Dunbar-Jacob J, et al. (2007) Primary care patients personal illness models for depression: relationship to coping behaviour and functional disability. Gen Hosp Psychiatry 29: 492-500.
18. McGrath PJ, Khan AY, Trivedi MH, Stewart JW, Morris DW, et al. (2008) Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. J Clin Psychiatry 69: 1847-55.
19. Stewart JW, Mcgrath PJ, Quitkin FM, Klein DF, (2009) DSM-IV Depression with Atypical Features: It is Valid? Neuropsychopharmacol 34: 2625-2632.
20. Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, et al. (2002) Atypical depression: a reappraisal. Am J Psychiatry 159: 1470-9.
21. Posternak MA, Zimmerman M, (2002) Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psychiatry 59: 70-6.
22. Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, et al. (2005) Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry 66: 1002-11.
23. Stewart JW, Mcgrath PJ, Quitkin FM, Klein DF, (2007) Atypical depression: current status and relevance to melancholia. Acta Psychiatr Scand 115: 58-71.
24. Roca M, García-Toro M, García-Campayo J, Vives M, Armengol S, et al. (2011) Clinical differences between early and late remission in depressive patients. J Affect Disord 134: 235-41.
25. Rush AJ, Guillion CM, Basco MR, Jarret RB, Trivedi MH, (1996) The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26: 477-86.
26. Gili M, Luciano JV, Bauzá N, Aguado J, Serrano MJ, et al. (2011) Psychometric properties of the IDS-SR30 for the assessment of depressive symptoms in Spanish population. BMC Med Res Methodol 11: 131.
27. Levitan RD, Atkinson L, Pedersen R, Buis T, Kennedy SH, et al. (2009) A novel examination of atypical major depressive disorder based on attachment theory. J Clin Psychiatry 70: 879-87.
28. Parker G, Roy K, Hadzi-Pavlovic D, Wilhelm K, Mitchell P, (2001) The differential impact of age on the phenomenology of melancholia. Psychol Med 31: 1231-6.
29. Rush AJ, Weissenburger JE, (1994) Melancholic symptom features and DSM-IV. Am J Psychiatry 151: 489-98.
30. Uher R, Dernovsek MZ, Mors O, Hauser J, Souery D, et al. (2011) Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. J Affect Disord 132: 112-20.
31. Asnis GM, Mcginn LK, Sanderson WC, (1995) Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry 152: 31-6.
32. Derecho CN, Wetzler S, Mcginn LK, Sanderson WC, Asnis GM, (1996) Atypical depression among psychiatric inpatients: clinical features and personality traits. J Affect Disord 39: 55-9.
33. Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K, (2002) Towards validation of atypical depression in the community: results of the Zurich cohort study. J Affect Disord 72: 125-38.
34. Stewart JW, Mcgrath PJ, Rabkin JG, Quitkin FM, (1993) Atypical depression: a valid clinical entity? Psych. Clin North Am 16: 479-495.
35. Stewart JW, McGrath PJ, Fava M, Wisniewski SR, Zisook S, et al. (2010) Do atypical features affect outcome in depressed outpatients treated with citalopram? Int J Neuropsychopharmacol 13: 15-30.
36. Davidson JR, Miller RD, Turnbull CD, Sullivan JL, (1982) Atypical depression. Arch Gen Psychiatry 39: 527-34.
37. Horwath E, Johnson J, Weissman MM, Hornig CD, (1992) The validity of major depression with atypical features based on a community study. J Affect Disord 26: 117-125.
38. Brown WA, (2007) Treatment response in melancholia. Acta Psychiatr Scand 115: 125-129.
39. Peselow ED, Sanfilipo MP, Difiglia C, (1992) Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 149: 1324-1334.
40. Roose SP, Glassman AH, Woodring S, (1994) Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151: 1735-9.
41. Heiligenstein JH, Tollefson GD, Faries DE, (1993) A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression melancholia. Int Clin Psychopharmacol 8: 247-51.
42. Tzanakaki M, Guazzelli M, Nimatousdis I, Zissis NP, Smeraldi E, et al. (2000) Increased remission rates with venlafaxine compared with major depression and melancholia. Int Clin Psychopharmacol 15: 29-34.
43. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, et al. (1990) Atipical depression, panic attacks, and response to imipramine and phenelzine. A replication. Arch Gen Psychiatry 47: 935-41.
44. Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, et al. (2002) Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust N Z J Psychiatry 36: 384-91.
45. Lonnqvist J, Sihvo S, Syvälahti E, Kiviruusu O, (1994) Moclobemide and fluoxetine in atypical depression: a double-blind trial. J Affect Disord 32: 169-77.
46. Søgaard J, Lane R, Latimer P, Behnke K, Christiansen PE, et al. (1999) A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression. J Psychopharmacol 13: 406-14.
47. Coryell W, (2007) The facets of melancholia. Acta Psychiatr Scand 115: 31-36.
48. Parker G, (2007) Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatr Scand 115: 21-30.
49. Bolwig TG, Madsen TM, (2007) Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis. Acta Psychiatr Scand 433: 130-5.
50. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, et al. (2001) ECT remission rates in psychotic versus nonpsychotic patients: a report from CORE. J ECT 17: 244-53.